3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
2
Pancreatic Cancer Non-resectable
1
Neoplasms
1
Interventions
Gemcitabine
3
Leucovorin
2
Fluorouracil
2
pamrevlumab
1
irinotecan sucrosofate
1
folfirinox
1
Taxes
1
Oxaliplatin
1
Irinotecan
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Pancreatic Cancer Non-resectable
×
pamrevlumab
×
Clear all
NCT03941093
2024-11-05
LAPIS
Kyntra Bio
Phase 3
Completed
284 enrolled
14 charts